{"id":"NCT00225277","sponsor":"Takeda","briefTitle":"Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus","officialTitle":"A Double-Blind, Randomized, Comparator-Controlled Study In Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus Glimepiride on the Rate of Progression of Coronary Atherosclerotic Disease as Measured by Intravascular Ultrasound","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-07","primaryCompletion":"2007-10","completion":"2007-10","firstPosted":"2005-09-23","resultsPosted":"2009-06-10","lastUpdate":"2012-02-28"},"enrollment":547,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Pioglitazone","otherNames":["ACTOSÂ®","AD4833"]},{"type":"DRUG","name":"Glimepiride","otherNames":[]}],"arms":[{"label":"Pioglitazone QD","type":"EXPERIMENTAL"},{"label":"Glimepiride QD","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to determine the efficacy of pioglitazone, once daily (QD), compared to glimepiride on atherosclerotic disease measured by intravascular ultrasound.","primaryOutcome":{"measure":"Nominal Change From Baseline in Percent Atheroma Volume","timeFrame":"Baseline and Final Visit (up to 72 weeks)","effectByArm":[{"arm":"Pioglitazone QD","deltaMin":40.592,"sd":0.6925},{"arm":"Glimepiride QD","deltaMin":40.016,"sd":0.6663}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"}]},"eligibility":{"minAge":"35 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":17},"locations":{"siteCount":79,"countries":["United States","Argentina","Canada","Chile"]},"refs":{"pmids":["18378631","19744248","21211686"],"seeAlso":["http://general.takedapharm.com/content/file/pi.pdf?applicationcode=ab2d7112-8eb3-465a-8fda-35018a9eafb0&fileTypeCode=ACTOSPI"]},"adverseEventsSummary":{"seriousAny":{"events":76},"commonTop":["Hypoglycaemia","Oedema Peripheral","Non-Cardiac Chest Pain","Dizziness","Weight Increased"]}}